Optimal timing of chemoradiation after resection or biopsy of glioblastomas: a nationwide population-based study
Dongeun Lee, Eunyoung Lee, Tae Hoon Roh, Se-Hyuk Kim · 2024
Read Optimal timing of chemoradiation after resection or biopsy of glioblastomas: a nationwide population-based study by Dongeun Lee, Eunyoung Lee, Tae Hoon Roh, Se-Hyuk Kim (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11590524.txt.
Description
Dongeun Lee and co-authors ask when combined chemo and radiation should start in a 2024 study on glioblastoma, an aggressive brain tumor. After surgery or biopsy, patients get both treatments together. Whether the wait before that joint treatment changes survival was not settled.
Nationwide insurance records in South Korea covered 3,586 patients treated from 2008 to 2021. Patients were split into early starters, within 21 days, and late starters, past 21 days. Each timing group was split again by surgery type, biopsy alone or fuller removal. Survival was then compared across the groups, giving doctors data for a choice they face in the first weeks after surgery.
Catalog record
| CREATOR | Dongeun Lee, Eunyoung Lee, Tae Hoon Roh, Se-Hyuk Kim |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |